Literature DB >> 22818121

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Kyong-Ah Yoon1, Hyekyoung Yoon, Sohee Park, Hee-Jin Jang, Jae Ill Zo, Hyun-Sung Lee, Jin Soo Lee.   

Abstract

OBJECTIVES: MicroRNAs (miRNAs) are widely known for their function as regulators of gene expression via translational repression. Polymorphisms in miRNAs have been shown to affect the regulatory capacity of miRNAs by influencing miRNA processing and/or miRNA-mRNA interactions. The purpose of this study was to investigate the association between 7 single nucleotide polymorphisms (SNPs) commonly found in precursor miRNA (pre-miRNA) and primary miRNA (pri-miRNA) sequences and the recurrence of disease in patients who underwent a complete resection of non-small cell lung cancer (NSCLC).
METHODS: Five SNPs found in pre-miRNAs (rs11614913/miR-196a2, rs2910164/miR-146a, rs6505162/miR-423, rs2289030/miR-492, and rs895819/miR-27a) and 2 SNPs found in pri-miRNAs (rs7372209/miR-26a-1 and rs213210/miR-219-1) were genotyped in 388 patients with NSCLC.
RESULTS: Among 388 patients, variants of the rs2910164 SNP were significantly associated with recurrence-free survival (RFS) (P = .016, log-rank test). When the results were subdivided by the tumor stage, variants of the rs2910164 and rs11614913 SNPs positively correlated with a better RFS (adjusted hazard ratio [HR], 0.48; 95% confidence interval [CI], 0.28-0.80; adjusted HR, 0.60; 95% CI, 0.38-0.94, respectively) in patients with stage II and stage III disease. Moreover, RFS significantly improved in patients with higher numbers of variant alleles in the rs2910164 and rs11614913 SNPs.
CONCLUSIONS: Our findings suggest that polymorphisms in the rs2910164 of miR-146a and the rs11614913 of miR-196a2 are associated with prognosis in patients with completely resected NSCLC.
Copyright © 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22818121     DOI: 10.1016/j.jtcvs.2012.06.030

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  31 in total

1.  MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.

Authors:  Youchao Jia; Aimin Zang; Yanhong Shang; Hua Yang; Zizheng Song; Zhiyu Wang; Lili Ren; Yaning Wei; Ling Hu; Hongyun Shi; Hefei Li
Journal:  Med Oncol       Date:  2014-08-26       Impact factor: 3.064

2.  Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2.

Authors:  Mario Acunzo; Giulia Romano; Dario Palmieri; Alessandro Laganá; Michela Garofalo; Veronica Balatti; Alessandra Drusco; Mario Chiariello; Patrick Nana-Sinkam; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

3.  Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population.

Authors:  Guo-Liang Huang; Mei-Ling Chen; Ya-Zhen Li; Yan Lu; Xing-Xiang Pu; Yu-Xiang He; Shu-Yin Tang; Hua Che; Ying Zou; Congcong Ding; Zhiwei He
Journal:  J Hum Genet       Date:  2014-01-16       Impact factor: 3.172

4.  Evaluation of miR-27a, miR-181a, and miR-570 genetic variants with gallbladder cancer susceptibility and treatment outcome in a North Indian population.

Authors:  Annapurna Gupta; Aarti Sharma; Anu Yadav; Neeraj Rastogi; Sushma Agrawal; Ashok Kumar; Vijay Kumar; Sanjeev Misra; Balraj Mittal
Journal:  Mol Diagn Ther       Date:  2015-10       Impact factor: 4.074

5.  MicroRNA-196a2 Biomarker and Targetome Network Analysis in Solid Tumors.

Authors:  Eman A Toraih; Manal S Fawzy; Eman A Mohammed; Mohammad H Hussein; Mohamad M El-Labban
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

Review 6.  The role of microRNAs in lung cancer progression.

Authors:  Wen-Cheng Zhang; Jinbo Liu; Xiangying Xu; Guangshun Wang
Journal:  Med Oncol       Date:  2013-08-08       Impact factor: 3.064

Review 7.  Clinico-Pathological Importance of miR-146a in Lung Cancer.

Authors:  Javaid Ahmad Wani; Sabhiya Majid; Andleeb Khan; Azher Arafah; Ajaz Ahmad; Basit Latief Jan; Naveed Nazir Shah; Mohsin Kazi; Muneeb U Rehman
Journal:  Diagnostics (Basel)       Date:  2021-02-10

8.  Effects of common polymorphism rs11614913 in Hsa-miR-196a2 on lung cancer risk.

Authors:  Zhengrong Yuan; Xu Zeng; Dan Yang; Weilu Wang; Zhihua Liu
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

9.  Pre-miR-27a rs895819A/G polymorphisms in cancer: a meta-analysis.

Authors:  Qian Xu; Cai-Yun He; Jing-Wei Liu; Yuan Yuan
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

Review 10.  Polymorphisms of microRNA sequences or binding sites and lung cancer: a meta-analysis and systematic review.

Authors:  Zhiwei Chen; Ling Xu; Xiangyun Ye; Shengping Shen; Ziming Li; Xiaomin Niu; Shun Lu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.